SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-21-010651
Filing Date
2021-10-20
Accepted
2021-10-20 17:56:57
Documents
2
Period of Report
2021-10-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54042.html 3  
1 PRIMARY DOCUMENT marketforms-54042.xml 3 1733
2 POA DOCUMENT poa.htm EX-24 3845
  Complete submission text file 0001214659-21-010651.txt   7087
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hohneker John (Reporting) CIK: 0001695378 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 211335081